Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

Ray Therapeutics, Forge Biologics announce viral vector contract development and cGMP manufacturing partnership

Posted on March 1, 2022 (March 25, 2022) by Forge Biologics
0/5 (0 Reviews)
Posted in Biologics News, In the news

Post navigation

 Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing PartnershipRay Therapeutics, Forge Biologics Enter Gene Therapy Mfg. Pact 
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree